Updated Mar 23, 2026 by GameVault System
Daicel Corporation reported a 17.9% year-on-year increase in sales revenue to 404.5 billion yen for the third quarter ending March 2023, driven by price revisions and favorable foreign exchange impacts.
Operating income declined by 6.9% to 36.6 billion yen due to rising costs for raw materials, fuel, and logistics, alongside weakened demand in key sectors.
Performance was negatively impacted by sluggish automobile production, semiconductor shortages, and COVID-19-related lockdowns in China, which hindered recovery in the automotive and LCD panel markets.
While the Materials and Engineering Plastics segments exceeded internal profit plans, the Medical/Healthcare, Smart, and Safety segments performed below expectations.
The company is implementing corrective measures including rigorous expense reviews and inventory reduction, while focusing on growth in high-demand areas like acetate tow and cosmetic ingredients.
A comprehensive revision of the mid-term management strategy is scheduled for release in May 2023 alongside the full-year financial results to address current market realities.
Daicel Corporation reported a 17.9% year-on-year increase in sales revenue to 404.5 billion yen for the third quarter ending March 2023, driven by price revisions and favorable foreign exchange impacts.
Operating income declined by 6.9% to 36.6 billion yen due to rising costs for raw materials, fuel, and logistics, alongside weakened demand in key sectors.
Performance was negatively impacted by sluggish automobile production, semiconductor shortages, and COVID-19-related lockdowns in China, which hindered recovery in the automotive and LCD panel markets.
While the Materials and Engineering Plastics segments exceeded internal profit plans, the Medical/Healthcare, Smart, and Safety segments performed below expectations.
The company is implementing corrective measures including rigorous expense reviews and inventory reduction, while focusing on growth in high-demand areas like acetate tow and cosmetic ingredients.
A comprehensive revision of the mid-term management strategy is scheduled for release in May 2023 alongside the full-year financial results to address current market realities.